XP Inc.XPNASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 78% recommend buying.

Consensus Rating
Buy
9 analysts·Limited coverage
78%
Rating Distribution
Strong Buy
00%
Buy
778%
Hold
222%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 44% higher.

Bear Case
$25.00
+44%
Consensus
$25.00
+44%
Bull Case
$25.00
+44%
Price Range9 analysts
Low
Consensus
High
$25.00
$25.00
Current Target
Current Price
$17.41
Upside to Target
$7.59

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$10.92(4 analysts)
P/E10x
Current: 9.8x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+14.02%
EPS+12.98%
FY2028
Rev+4.77%
EPS+8.80%
FY2029
Rev+13.29%
EPS

Earnings Surprises

Beat rate:17%(2/12 quarters)
Avg surprise:-9.9%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 16, 2025UBS
XP Inc. price target raised to $25 from $23 at UBS
Target:$25.00
+42.2%from $17.59
Oct 16, 2025UBS
XP Inc. price target lowered to $23 from $24 at UBS
Target:$23.00
+39.1%from $16.53
Jul 11, 2024UBS
XP Inc. downgraded to Neutral from Buy at UBS
Target:$21.00
+15.1%from $18.25
Jul 2, 2024Bradesco
XP Inc. assumed with Neutral from Outperform at Bradesco BBI
Target:$19.00
+13.8%from $16.70
Apr 30, 2024Goldman Sachs
Goldman Sachs Downgrades XP Inc. (XP) to Neutral, 'Waiting for (much) lower rates'
Target:$23.00
+7.4%from $21.42
Apr 22, 2024Morgan Stanley
XP Inc. downgraded to Equal Weight from Overweight at Morgan Stanley
Target:$24.00
+13.7%from $21.11
Jan 24, 2024Bradesco
Bradesco BBI Upgrades XP Inc. (XP) to Outperform
Target:$32.00
+25.6%from $25.47
Jul 20, 2023Credit Suisse
Credit Suisse Upgrades XP Inc. (XP) to Neutral
Target:$26.00
+9.2%from $23.82
Jun 10, 2022HSBC
XP (XP) Stock Price: $33 Target And Buy Rating
Target:$33.00
+61.1%from $20.48